← Back to catalogue

Quanta Lite Ribosome P Elisa

FDA 510(k)FDA UDI

Class II (US FDA 510(k))

510(k) K981237

by Inova Diagnostics, Inc.

Identity

Trade Name
QUANTA Lite® Ribosome P ELISA FDA UDI
Generic Name
Ribosomal phosphoprotein antibody IVD, kit, enzyme immunoassay (EIA) FDA UDI
Device Name
1. 1x Ribosome P ELISA microwell plate (12-1 x 8 wells), with holder 2. 1x 1.2mL prediluted ELISA Negative Control 3. 1x 1.2mL prediluted Ribosome P ELISA Low Positive 4. 1x 1.2mL prediluted Ribosome P ELISA High Positive 5. 1x 50mL HRP Sample Diluent 6. 1x 25mL HRP Wash Concentrate, 40x concentrate 7. 1x 10mL HRP IgG Conjugate, (goat), anti-human IgG 8. 1x 10mL TMB Chromogen 9. 1x 10mL HRP Stop Solution, 0.344M Sulfuric Acid FDA UDI
Model / Reference
708600 FDA UDI
Description
1. 1x Ribosome P ELISA microwell plate (12-1 x 8 wells), with holder 2. 1x 1.2mL prediluted ELISA Negative Control 3. 1x 1.2mL prediluted Ribosome P ELISA Low Positive 4. 1x 1.2mL prediluted Ribosome P ELISA High Positive 5. 1x 50mL HRP Sample Diluent 6. 1x 25mL HRP Wash Concentrate, 40x concentrate 7. 1x 10mL HRP IgG Conjugate, (goat), anti-human IgG 8. 1x 10mL TMB Chromogen 9. 1x 10mL HRP Stop Solution, 0.344M Sulfuric Acid FDA UDI

Identifiers

Primary DI / UDI-DI
08426950506348 FDA UDI
510(k) Number
K981237 FDA 510(k)FDA UDI
FDA Product Code
MQA FDA 510(k)FDA UDI
GMDN Term
Ribosomal phosphoprotein antibody IVD, kit, enzyme immunoassay (EIA) FDA UDI

Classification

Device Class
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 866.5100 FDA 510(k)
Regulation Number
866.5100 FDA 510(k)FDA UDI
Advisory Committee
Immunology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

The Quanta Lite Ribosome P Elisa is an in vitro diagnostic test used to detect ribosome P antibodies in human serum, utilizing enzyme-linked immunosorbent assay (ELISA) technology. It is classified as an Anti-Ribosomal P Antibodies device. The device is used for semi-quantitative detection of autoantibodies in human serum. The Quanta Lite Ribosome P Elisa is a medical device in the field of Immunology. It is designed for anti-Ribosome P antibody detection, aiding in the diagnosis of diseases such as SLE.

The Quanta Lite Ribosome P Elisa is supplied by Inova Diagnostics, Inc. and has been cleared under the FDA 510(k) premarket notification, with the clearance number K981237. The device is classified as a class 2 device, with the regulation number 866.5100. The Quanta Lite Ribosome P Elisa is intended for use in a laboratory setting, with the device utilizing ELISA technology to detect ribosome P antibodies in human serum.

Frequently asked questions

What is the Quanta Lite Ribosome P ELISA used for?

The Quanta Lite Ribosome P ELISA is an in vitro diagnostic test designed to detect ribosome P antibodies in human serum. These antibodies are associated with autoimmune diseases, particularly systemic lupus erythematosus (SLE). By using enzyme-linked immunosorbent assay (ELISA) technology, the test provides a semi-quantitative measurement of autoantibody levels, helping clinicians diagnose or monitor conditions linked to anti-ribosome P antibodies.

How is the Quanta Lite Ribosome P ELISA supplied, and where is it used?

The Quanta Lite Ribosome P ELISA is supplied by Inova Diagnostics, Inc. and is intended exclusively for use in laboratory settings. The kit includes all necessary reagents and components for performing the ELISA test on human serum samples, ensuring accurate detection of ribosome P antibodies under controlled conditions.

Is the Quanta Lite Ribosome P ELISA single-use or reusable?

The Quanta Lite Ribosome P ELISA is designed for single-use per test run. Each kit is intended for a specific number of tests as outlined in the accompanying instructions, ensuring consistency and reliability in results. Reuse of components is not recommended, as it could compromise accuracy or sterility.

What regulatory clearance does the Quanta Lite Ribosome P ELISA hold?

The Quanta Lite Ribosome P ELISA has been cleared under the FDA’s 510(k) premarket notification process, with clearance number K981237. This classification confirms that the device is substantially equivalent to a legally marketed predicate device and meets regulatory standards for safety and effectiveness in detecting anti-ribosome P antibodies.

How should the Quanta Lite Ribosome P ELISA be stored?

Storage instructions for the Quanta Lite Ribosome P ELISA are detailed in the product documentation provided by Inova Diagnostics. Generally, ELISA kits require refrigeration (typically between 2°C and 8°C) to maintain stability and integrity of the reagents. Avoid freezing, exposure to direct sunlight, or contamination with moisture or chemicals. Always follow the manufacturer’s guidelines to preserve test accuracy.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: QUANTA LITE RIBOSOME P ELISA (K981237) — FDA 510(k) | Innolitics, QUANTA Lite | Werfen North America, QUANTA Lite (R) Ribosome P Reagents | Werfen North America, Quanta Lite Ribosome P Elisa 510 (k) FDA Premarket Notification K981237 ..., QUANTA LITE RIBOSOME P ELISA (K981237) — FDA 510(k) | Innolitics

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA 510(k) K981237 24 fields · synced Oct 1, 2026
  • FDA UDI 6745947d-599e-400f-b89f-95164b99dcc8 36 fields · synced May 27, 2026